Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1164.4000 6.80 (0.59%)
NSE May 09, 2025 15:31 PM
Volume: 645.5K
 

logo
Aurobindo Pharma Ltd.
15 Aug 2023
1164.40
0.59%
buy
by BOB Capital Markets Ltd.
Target: 880
BOB Capital Markets Ltd.
Q1 revenue/EBITDA beat consensus by 4%/9% with adj. PAT (ex-one-off charge) running 15% ahead
 
Number of FII/FPI investors decreased from 730 to 724 in Mar 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - May 09, 2025
The Baseline | 09 May 2025
Market closes lower, Intellect Design Arena's Q4 net profit surges 93% QoQ to Rs 135.3 crore
Trendlyne Marketwatch | 09 May 2025
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020